ESR1 and breast cancer: Notably, different BC subtypes display significant heterogeneity in ERS responses: in estrogen receptor-positive (ER+) breast cancer, moderate ERS activation promotes cellular adaptation, whereas sustained activation induces apoptosis through mitochondria-associated endoplasmic reticulum membrane-mediated calcium signaling and ROS production [15, 16].